Decuyper Ine I, Green Brett J, Sussman Gordon L, Ebo Didier G, Silvers William S, Pacheco Karin, King Bradley S, Cohn John R, Zeiger Robert S, Zeiger Joanna S, Naimi David R, Beezhold Donald H, Nayak Ajay P
Department of Immunology-Allergology-Rheumatology, Antwerp University Hospital, University of Antwerp, Antwerp, Belgium; Infla-Med Centre of Excellence University of Antwerp, Antwerp, Belgium.
Office of the Director, Health Effects Laboratory Division, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, Morgantown, Wv.
J Allergy Clin Immunol Pract. 2020 Nov-Dec;8(10):3331-3338. doi: 10.1016/j.jaip.2020.09.003.
Within the last decade there has been a significant expansion in access to cannabis for medicinal and adult nonmedical use in the United States and abroad. This has resulted in a rapidly growing and diverse workforce that is involved with the growth, cultivation, handling, and dispensing of the cannabis plant and its products. The objective of this review was to educate physicians on the complexities associated with the health effects of cannabis exposure, the nature of these exposures, and the future practical challenges of managing these in the context of allergic disease. We will detail the biological hazards related to typical modern cannabis industry operations that may potentially drive allergic sensitization in workers. We will highlight the limitations that have hindered the development of objective diagnostic measures that are essential in separating "true" cannabis allergies from nonspecific reactions/irritations that "mimic" allergy-like symptoms. Finally, we will discuss recent advances in the basic and translational scientific research that will aid the development of diagnostic tools and therapeutic standards to serve optimal management of cannabis allergies across the occupational spectrum.
在过去十年中,美国国内外用于医疗和成人非医疗用途的大麻获取途径有了显著扩展。这导致了一支迅速壮大且多样化的劳动力队伍,他们涉及大麻植物及其产品的种植、培育、处理和分发。本综述的目的是让医生了解与接触大麻的健康影响相关的复杂性、这些接触的性质,以及在过敏性疾病背景下管理这些问题未来面临的实际挑战。我们将详细阐述与典型现代大麻产业运营相关的生物危害,这些危害可能会促使工人发生过敏致敏。我们将强调阻碍客观诊断措施发展的局限性,而这些措施对于区分“真正的”大麻过敏与“模拟”过敏样症状的非特异性反应/刺激至关重要。最后,我们将讨论基础和转化科学研究的最新进展,这些进展将有助于开发诊断工具和治疗标准,以实现对职业领域大麻过敏的最佳管理。